JNJ-77242113 Shows Greater Efficacy Than Placebo for Plaque Psoriasis

THURSDAY, Feb. 8, 2024 -- For patients with moderate-to-severe plaque psoriasis, the interleukin-23-receptor antagonist peptide JNJ-77242113 shows greater efficacy than placebo, according to a study published in the Feb. 8 issue of the New England...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news